Testing effectiveness (Phase 2)Ended earlyNCT00020969
What this trial is testing
Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
CTI BioPharma